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Most of the anticancer agents cannot be efficiently delivered into the brain tumor because
of the existence of blood-brain tumor barrier (BTB). The objective of this study was to
explore the effect of microbubble-enhanced diagnostic ultrasound (MEUS) on the BTB
permeability and the possible mechanism. Glioma-bearing rats were randomized into
three groups as follows: the microbubble-enhanced continued diagnostic ultrasound
(MECUS) group; the microbubble-enhanced intermittent diagnostic ultrasound (MEIUS)
group and the control group. The gliomas were insonicated through the skull with
a diagnostic ultrasound and injected with microbubbles through the tail veins. Evans
Blue (EB) and dynamic contrast-enhanced-MRI were used to test changes in the BTB
permeability. Confocal laser scanning microscopy was used to observe the deposition
of the EB in the tumor tissues. The distribution and expression of junctional adhesion
molecule-A (JAM-A) and calcium-activated potassium channels (KCa channels) were
detected by a Western blot, qRT-PCR, and immunohistochemical staining. In the MEUS
groups, the EB extravasation (11.0 ± 2.2 µg/g in MECUS group and 17.9 ± 2.3 µg/g in
MEIUS group) exhibited a significant increase compared with the control group (5.3± 0.9
µg/g). The MEIUS group had more EB extravasation than the MECUS group. The
Ktrans value of the dynamic contrast-enhanced-MRI in the MEUS groups was higher
than that of the control group and correlated strongly with the EB extravasation in the
tumor (R2 = 0.97). This showed that the Ktrans value might be a non-invasive method
to evaluate the BTB permeability in rat glioma after microbubble-enhanced ultrasound
treatment.Western blot, qRT-PCR and immunohistochemical staining revealed that
MEUS increased the KCa channels expression and reduced JAM-A expression in glioma.
This change wasmore obvious in the MEIUS group than in the MECUS group. The results
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demonstrated that MEUS effectively increased the BTB permeability in glioma. The
mechanisms might involve the up-regulation of KCa channels expression and affecting
the formation of tight junctions in the BTB by a reduction of JAM-A expression. These
findings might provide some new guidance for glioma drug therapy.
Keywords: glioma, blood-brain tumor barrier, permeability, diagnostic ultrasound, dynamic
contrast-enhanced-MRI
INTRODUCTION
Blood-brain barrier (BBB) is a major limitation to the use of
drugs in the brain. Some studies show that nearly 100% of
macromolecular and 98% of micromolecular drugs cannot pass
through the BBB (Pardridge, 2007). This limitation affects the
development of effective drugs for many brain diseases. Studies
show that the glioma vasculature permeability is heterogeneous,
and there are barriers to drug therapy, such as edema and
increased interstitial pressures (Fukumura and Jain, 2007).
Furthermore, although the blood vessels in glioma often do not
have a fully intact BBB and are somewhat permeable, the feeding
capillaries reserve the characteristics of the BBB and form a
blood-brain tumor barrier (BTB, Hu et al., 2007; Eichler et al.,
2011). BTB is similar to BBB, which is located between tumor
cells and microvessels formed by highly specialized endothelial
cells. Although the permeability of BTB is higher than that of
BBB (Yuan et al., 1994), the existence of a BTB obviously limits
the delivery of drugs into glioma. Techniques that can help drugs
pass across the BTB could enable the use of many anti-tumor
agents in glioma therapy.
Previous studies have demonstrated that microbubbles
increase the possibility of acoustic cavitation and cavitation-
related vascular damage effects, such as microvascular rupture
and petechial hemorrhage (Miller and Gies, 2000a; Miller and
Quddus, 2000b; Miller, 2007), in which microbubbles served
as cavitation nuclei to induce cavitation (Miller and Thomas,
1995). These vascular effects could be therapeutically useful in
thrombolysis and gene or drug delivery (Molina et al., 2006;
Ferrara et al., 2007; Xie et al., 2009; Kutty et al., 2014; Sato
et al., 2015; Burgess and Hynynen, 2016). Recently, some studies
showed that the permeability of the BTB is increased by focused
ultrasound and low-frequency ultrasound in the presence of an
ultrasound contrast agent (Liu et al., 2006; Hynynen, 2008; Xia
et al., 2012; Diaz et al., 2014; Aryal et al., 2015). This technique
non-invasively enhances the uptake of drugs or genes to the
targeted glioma tissues (Diaz et al., 2014; Aryal et al., 2015).
The above effect is reversible, allowing for a time window for
drug delivery to the target site of the brain tumor. However, the
potential molecular mechanism involved in this process still need
to be investigated.
In general, there are two pathways for drugs to cross the BTB:
transcellular pathway and paracellular pathway. The paracellular
pathway is often regarded as the main path for the absorption of
Abbreviations: BTB, blood-brain tumor barrier; MEUS, microbubble-enhanced
diagnostic ultrasound; MEIUS, microbubble-enhanced intermittent diagnostic
ultrasound; MECUS, microbubble-enhanced continued diagnostic ultrasound;
DCE-MRI, dynamic contrast-enhanced-MRI.
hydrophilic drugs (peptides, proteins, etc.; (Salama et al., 2006)).
Ningaraj et al. showed that KCa channels played an important
role in the transcellular pathway regulation of BTB permeability.
These channels were effective targets for regulating the formation
of transport vesicles in both the glioma capillary endothelium and
tumor cells (Ningaraj et al., 2003). And there is no report about
the changes of calcium-activated potassium channels expression
following ultrasound irradiation and microbubbles.
The BBB has complex tight junctions and an inactive
endocytic transport (Jolliet-Riant and Tillenment, 1999). Integral
tight junction proteins are claudins, occluding, and junctional
adhesion molecules (JAMs). JAM-A is implicated in a variety of
physiologic and pathologic processes involving cellular adhesion,
such as tight junction assembly (Yeung et al., 2008). Several
studies report that ultrasound irradiation and microbubbles can
open the BBB and decrease the expression of junctional proteins,
such as claudin-5 and occludin (Sheikov et al., 2008; Xia et al.,
2012). However, little is known about the changes of JAM-
A expression following the use of ultrasound irradiation and
microbubbles.
Therefore, in this study, we applied low-frequency diagnostic
ultrasound with microbubbles to increase the BTB permeability
in a rat C6 glioma model without damaging the brain tissue.
Then, we investigated the effects ofMEUS on the distribution and
expression levels of the KCa channels and JAM-A to elucidate the
possible mechanism involved in this process.
MATERIALS AND METHODS
Cell Culture
C6 glioma cells were obtained from the cell bank of the Chinese
Academy of Sciences (Shanghai, China). The cells were incubated
in DMEM/F12 medium (Gibco, Carlsbad, CA) supplemented
with 10% FBS and 100 units/ml penicillin (HyClone, Logan, AR)
at 37◦C in a humidified atmosphere containing 95% air and
5% CO2.
Animal Models
Ninety healthy adult male Sprague-Dawley rats weighting 230–
280 g were anesthetized and placed in a stereotaxic frame (RWD
Life Science, Shenzhen, China). Their uppermost cranial hair was
removed with the aid of clippers, whereby a midline incision
exposed the cranium. A burr hole was drilled in the skull 1mm
anterior to the bregma and 3mm lateral to the midline. The
microsyringe needle advanced to the depth of 5mm and 1 ×
106 C6 glioma cells, resuspended in 10 µL phosphate-buffered
saline (PBS), were injected to establish the in situ brain glioma
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model. Eight days after the glioma cell implantation, the rats were
prepared for the experiments.
The glioma-bearing rats were randomized into the control
group (n= 30), the microbubble-enhanced continued diagnostic
ultrasound (MECUS) group (n = 30), and the microbubble-
enhanced intermittent diagnostic ultrasound (MEIUS) group (n
= 30).
Ethics Statement
All the procedures were performed in accordance with the
approval of the Institutional Animal Care and Use Committee of
the Third Military Medical University, Daping Hospital. All the
animals received care in accordance with the Guide for the Care
and Use of Laboratory Animals. At the end of the experiment,
the animals were euthanized using an overdose of 10% chloral
hydrate.
Microbubble
Zhifuxian (Liu et al., 2011; Wu et al., 2014), a lipid-coated
microbubble, was used for the nucleation of acoustic cavitation.
It was prepared by lyophilization of two lipids suspension,
1,2-Dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) and
1,2-Distearoyl-sn–glycero-3-phosphoethanolamine (DSPE),
and agitating with perfluoropropane gas using a high-
speed mechanical amalgamator. The size distribution and
concentration of the microbubbles were determined by an
RC-3000 Resistance Particle Counter (OMEC Technology Co.,
Ltd. China). The microbubbles had a mean particle diameter of
2 µm, with 98% of the particles less than 8 µm and a bubble
concentration of 9× 1010/mL.
Treatment Protocols
All the tumor-bearing rats were anesthetized with 10% chloral
hydrate. The rats were fixed on the experimental table. Their
uppermost cranial hair was removed by 8% Na2S. An S5-
1 transducer (IE33; Philips ultrasound, Bothell WA, USA)
with a frequency of 1.7MHz was placed above the temporal
bone (with a depth of 5 cm), and the targeted tumor area
was kept at the ultrasound focal point by measuring the
distance between the tumor core and the temporal bone skin
through an MRI examination. Ultrasound gel was administered
between the transducer and the temporal bone. In the MECUS
group, the rats were directly insonated using a continued
ultrasound.The injected dose of microbubbles through the tail
vein was 1.5mL/kg. The duration of the ultrasound sonication
was 10min, and the mechanical index of the ultrasound was 1.3.
Continued ultrasound irradiation was replaced by intermittent
ultrasound (2-2s) irradiation in the MEIUS group. While in the
control group, the microbubbles were replaced by 1.5mL/kg
saline and a sham ustrasound insonation was applied instead of
the ultrasound irradiation.
Measurement of the BTB Permeability by
DCE-MRI
All the rats underwent an MRI with a Bruker BioSpec 7T/20 cm
system (Bruker, Ettlingen, Germany) using a head surface coil
before ultrasound irradiation. The sequences used in this study
were as follows: T2-weighted image (T2WI; repetition time =
2500ms, echo time = 45ms, field of view = 35mm × 35mm,
slice thickness= 0.5mm, NEX= 4, flip angle= 90◦).
One hour after the treatment, the rats (n = 6 for each group)
were subjected to the DCE-MRI to evaluate the increase BTB
permeability. To generate the T1 maps from the precontrast
images, the DCE FLASH images, with multiple flip angles of
5, 10, 15, and 20◦, were acquired. The following parameters
were used to acquire the DCE FLASH images: TR = 52.823ms;
TE = 1.765ms using a 128 × 128 matrix; FOV = 35mm ×
35mm; and NEX = 1. The effective slice thickness was 0.5mm.
To obtain the dynamic postcontrast DCE FLASH images, a
fixed flip angle of 15◦ was used, with 6.761 s for 540.907 s
(80 time points). Acquisition of the DCE FLASH images was
started before the administration of the contrast to obtain the
baseline T1 signals. When the third dynamic loop finished,
0.5mmol/ mL of Omniscan (GE Healthcare, Cork, Ireland)
was administered at a dosage of 0.1mmol/kg body weight by
hand push within 4 s. All the images were transferred to an
independent workstation for quantitative analysis by a non-
commercial software (OmniKinetics, GEHealthcare, China). The
reference region model was used to calculate the forward transfer
constant Ktrans.
Measurement of the BTB Permeability by
Evans Blue (EB)
Two percent EB (50mg/kg) was injected into each group of
rats through the tail vein before the microbubble injection 24 h
later after dynamic contrast-enhancd (DCE)-MRI scanning when
treatment was performed again. Then, rats were sacrificed using
an overdose of chloral hydrate 1 h after the treatment. The
rats were then infused with 0.9% heparinized saline in the left
ventricle until a colorless perfusion fluid was obtained from the
right atrium. Then, each tumor was cut into two halves: one
for the quantitative analysis of EB accumulation and the other
for the confocal laser scanning microscopy (CLSM) examination.
For the CLSM examination, the tumor parts were extracted for
frozen sectioning and cut into 5-mm slices at intervals of 0.8mm
immediately after the heparinized saline infusion. The frozen
sections were stained in 5mg/mL of DAPI (4′,6-diamidino-2-
phenylindole) dihydrochloride (Sigma, St. Louis, MO, USA) for
3min to mark the nuclei, followed by staining with an anti-fade
mounting medium (Beyotime, Shanghai, China). The images
were recorded using CLSM (TCS SP5; Leica, Wetzlar, Germany).
The EB and DAPI dihydrochloride were excited at 620 nm and
454 nm. For the quantitative analysis of EB, the tumor parts
were weighed and put into formamide (1mL/100mg) at 60◦C for
24 h. The concentration of the dye extracted from each brain was
determined by a spectrophotometer at 620 nm andwas compared
to a standard graph created through the recording of the optical
densities from serial dilutions of EB in 0.9% sodium chloride
solution.
Immunohistochemistry
The rats (n= 5 for each group) were sacrificed by an overdose of
chloral hydrate 1 h after the treatment. The brains were extracted
from the skull after a perfusion with 200mL of heparinized
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saline and then 200mL of 4% paraformaldehyde. Then, the brains
were place in fixative for 1 week and were then immersed in
a 30% sucrose solution with PBS for 4 days. Coronal sections
were serially cut into pieces at a thickness of 6 µm and at
intervals of 0.8mm on a cryostat. Before the immuno-staining,
they were rehydrated in PBS. Then, they were incubated with a
0.3% H2O2/methonal solution for 10min at room temperature
so that the endogenous peroxidase activity was inactivated. The
next step was to wash and block the sections using normal goat
serum. Then, the sections were incubated with a rabbit polyclonal
anti-JAM-A antibody (Abcam, Cambridge, UK) and a mouse
monoclonal anti-α-subunit of KCa channels antibody (Abcam,
Cambridge, UK) at 4◦C overnight. Negative controls were
obtained by using PBS instead of the primary antibody. The other
procedures were performed according to immunohistochemistry
standard procedures.
Quantitative Real Time-Polymerase Chain
Reaction (qRT-PCR)
The rats (n= 5 for each group) were sacrificed by an overdose of
chloral hydrate 1 h after the treatment and the tumor tissues were
obtained. The tissues were immediately frozen in liquid nitrogen
and stored at −80◦C. For qRT-PCR analysis of JAM-A and
α-subunit of KCa channels mRNA, total RNA was extracted from
tumor tissue using TrizolReagent. RNA samples were subjected
to qRT-PCR. Primers used for PCR amplification were as follows:
JAM-A (sense: 5′- CGGGACCCCTTGCTTTTATTC- 3′,
anti-sense: 5′- GAATGGGGAATGAAAACTTTGTAAC -3′), α-
subunit of KCa channels (sense: 5
′- CCGCTTTCTTCTGTCTCT
GTTAATG - 3′, anti-sense: 5′- TCGGGGATGTGTTGGGTGAG
-3′), β-actin (sense: 5′-GTGGGGCCCCAGGCACCA-3′,
anti-sense: 5′-GCTCGGCCGTGGTGGTGAAGC-3′). The
amplification cycling conditions were as follows: 95◦C for
10min, followed by 40 cycles at 95◦C for 10 s, 60◦C for 30 s and
72◦C for 20 s. The relative JAM-A and α-subunit of KCa channels
mRNA levels were calculated as 2∧−11Ct, where Ct represents
the threshold cycle. β-actin was used as the internal reference.
Western Blot Assessment
The tumor tissue (n = 5 for each group) was obtained after
infusing heparinized saline into the blood system. The proteins
were extracted, and a Western blot analysis was performed
as previously reported (Fang et al., 2013). All of the samples
were manipulated in equal conditions. Briefly, a 10% SDS-PAGE
was used to separate the protein samples (20mg), which were
transferred to a polyvinylidene difluoride membrane, probed
with a rabbit polyclonal anti-JAM-A antibody (diluted 1:2000,
Millipore, CA, USA), a mouse polyclonal anti-α-subunit of
Kca channels antibody (diluted 1:800, Millipore, CA, USA)
and a mouse polyclonal antibody β-actin (diluted 1:3000, Santa
Cruz Biotechnology Inc., Santa Cruz, CA) overnight at 4◦C.
After an incubation with secondary antibodies, the protein
expressions were detected by enhanced chemiluminescence
and were quantified using a Quantity One Software (Bio-Rad,
Hercules, CA).
Histological Examination
The rats (n= 9 for each group) were sacrificed by an overdose of
chloral hydrate 1 h after the treatment. The brains were extracted
from the skull after perfusion with 200mL of heparinized saline
and then 200mL of 4% paraformaldehyde. Then, the brains were
placed into a fixative for 1 week and were then immersed in a
30% sucrose solution with PBS for 4 days. Coronal sections were
serially cut into pieces at a thickness of 6 µm on a cryostat.
Every 30th section was stained with hematoxylin and eosin
and TUNEL for histological examination. TUNEL staining was
done with an apoptosis detection kit (Roche, USA) according to
the manufacturer’s instructions. Tumor regions were used as a
positive control in experiments. The sections were visualized by
two independent blinded observers.
Statistical Analysis
All the data are expressed as the mean ± standard deviation
values. A one-way analysis of variance was utilized to determine
the significant difference between multiple groups. A p < 0.05
was deemed statistically different. All the data were analyzed
using SPSS 18.0 software.
RESULTS
Measurement of the BTB Permeability
by EB
In the MEUS groups, the EB extravasation (11.0 ± 2.2 µg/g in
MECUS group and 17.9 ± 2.3 µg/g in MEIUS group) exhibited
a significant increase compared with the control group (5.3± 0.9
µg/g). The MEIUS group had more EB extravasation than the
MECUS group (p < 0.05) (Figure 1B). This result showed that
the blood vessels in glioma do not have a fully intact BBB, and
MEUS increased the BTB permeability. Furthermore, MEIUS
more obviously enhanced the BTB permeability than MECUS.
CLSM images showed similar results. There was deposition of
EB in tumor interstitium in all groups. In the MEUS groups,
the deposition of EB in the tumor interstitium exhibited a
significant increase compared with the control group. The
MEIUS group had a brighter red fluorescence than the MECUS
group (Figure 1A). The result showed that MEUS increased the
BTB permeability, and this was more obviously exhibited in
MEIUS than in MECUS.
Measurement of the BTB Permeability by
DCE-MRI
In the MEUS groups, the Ktrans value (0.1 ± 0.013min
−1
in MECUS group and 0.158 ± 0.01min−1 in MEIUS group)
was significantly increased compared with the control group
(0.061 ± 0.011min−1). The MEIUS group had a higher Ktrans
value than the MECUS group (p < 0.05) (Figure 2B). The
result demonstrated that MEUS increased the BTB permeability,
and this was exhibited more obviously in MEIUS than in
MECUS. The Ktrans map images showed similar results. In
the MEUS groups, the tumor color of the Ktrans map images
was brighter compared with the control group. The MEIUS
group exhibited this more obviously than the MECUS group
(Figure 2A). However, there were no obvious changes as tumor
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FIGURE 1 | Quantitative determination the EB extravasation in glioma.
(A) Confocal laser scanning microscopy images depicting the EB deposition in
glioma. The red fluorescence represents EB, and the blue fluorescence
represents the cell nuclei. The images show that the red fluorescence is
distributed in the tumor interstitium in all the groups. The red fluorescence in
the microbubble-enhanced ultrasound groups exhibited a significant increase
compared with the control group. The MEIUS group had a brighter red
fluorescence in the tumor interstitium than the MECUS group. (B) EB
extravasation (mean ± standard deviation) in the tumor tissues from three
different experimental groups (n = 6 for each group). *Indicates a significant
difference compared with the control group (p < 0.05). # Indicates a
significant difference compared with the microbubble-enhanced continued
diagnostic ultrasound (MECUS) group (p < 0.05).
tissue in the surrounding brain tissue after MEUS in the Ktrans
maps. These results demonstrated that MEUS increased the BTB
permeability, and MEIUS exhibited this more obviously than
MECUS.
Furthermore, we found the Ktrans value correlated strongly
with the EB extravasation in the tumor tissue (R2 = 0.97)
(Figure 3). This demonstrated that the Ktrans value could be used
as a non-invasive method to evaluate BTB permeability in rat
glioma after a microbubble-enhanced ultrasound treatment.
Distribution and Expression Changes of
JAM-A and the α-subunit of the KCa
Channels
Immunohistochemistry showed that the protein expression
of JAM-A and the α-subunit of the KCa were located
mainly in both the capillary endothelium and the tumor
cells in glioma (Figures 4A, 5A). In the MEUS groups, the
immunohistochemistry, qRT-PCR and Western blot results
confirmed that the mRNA and protein expression of JAM-A was
decreased compared with the control group, and in the MEIUS
group, it decreased more significantly than in the MECUS group
(Figure 4). These results demonstrated that MEUS decreased
JAM-A expression in glioma, and MEIUS exhibited this more
obviously than MECUS. In contrast, the immunohistochemistry,
qRT-PCR and Western blot results confirmed that the mRNA
and protein expression of the α-subunit of the KCa channels
FIGURE 2 | The Ktrans changes in the tumor tissues from the different
groups. (A) Representative Ktrans maps of rats with glioma in the different
groups. (B) Changes in the Ktrans value in the different groups were analyzed
(n = 6 for each group). The values represent the mean ± standard deviation.
* Indicates a significant difference compared with the control group (p < 0.05).
# Indicates a significant difference compared with the MECUS group (p <
0.05).
FIGURE 3 | Scatter plots and fitted linear correlation lines of the EB
content versus the Ktrans value in the tumor tissues. This figure shows
that the Ktrans value correlates strongly with the EB extravasation in the tumor
tissue (R2 = 0.97).
was increased compared with the control group, and the MEIUS
group increased more significantly than the MECUS group
(Figure 5). These results demonstrated that MEUS increased
expression of the α-subunit of the KCa channels in glioma, and
MEIUS exhibited this more obviously than MECUS.
Histologic Changes
The Hematoxylin-eosin-staining and TUNEL staining showed
that the brain tissues from the different groups did not differ
in alterations or microscopic damage. The histological structure
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FIGURE 4 | Distribution and expression changes of junctional adhesion
molecule-A (JAM-A) in the tumor tissues from the different groups
(scale bar = 20um). (A) Distribution and expression of JAM-A by
immunohistochemistry. (B) The JAM-A protein expression changes by a
Western blot analysis in the tumors from the different groups. The result from
each group was normalized to β-actin. The quantification of JAM-A expression
was performed by scanning the intensity of the densitometry value (n = 5 for
each group; values represent the mean ± standard deviation). (C) The JAM-A
mRNA expression changes by a qRT-PCR analysis in the tumors from the
different groups (n = 5 for each group; values represent the mean ± standard
deviation).*Indicates a significant difference compared with the control group
(p < 0.05). # Indicates a significant difference compared with MECUS group (p
< 0.05).
was normal, and no hemorrhages, inflammation, apoptosis or
other abnormalities were observed (Figures 6, 7). These results
demonstrated that MEUS did not cause damage to the normal
brain tissue in this study.
DISCUSSION
Malignant glioma has a high recurrence and mortality rate. The
current strategies involve surgical debulking, radiation therapy,
and chemotherapy. Drug therapy plays an important role in
the treatment of malignant gliomas (Mathieu and Fortin, 2006;
Nieder et al., 2009). However, various parts of glioma with a
mainly intact BTB may be shielded from many drugs (Black
and Ningaraj, 2004). Therefore, there is an urgent need to
open the BTB to improve drug therapy for glioma. Recently,
the most widely used ultrasound device applied in MEUS is
the focused ultrasound therapy apparatus. Therapeutic drugs
have been delivered successfully to tumor tissues with focused
ultrasound (Diaz et al., 2014; Aryal et al., 2015). However, focused
ultrasound usually needs an appropriate image-monitoring
system. Therefore, we tried to use diagnostic ultrasound, which
is more convenient and economical for mediating microbubble
destruction. Low-frequency ultrasound penetrates into tissue
easily with few sound energy absorptions and little tissue damage
FIGURE 5 | Distribution and expression changes of the α-subunit of the
calcium-activated potassium channels (KCa channels) in the tumor
tissues from the different groups (scale bar = 20um). (A) Distribution and
expression of the α-subunit of the KCa channels by immunohistochemistry. (B)
The α-subunit of the KCa channels protein expression changes by a Western
blot analysis in the tumors from the different groups. The quantification of the
α-subunit of the KCa channels expression was performed by scanning the
intensity of the densitometry value (n = 5 for each group; values represent the
mean ± standard deviation). (C) The α-subunit of the KCa channels mRNA
expression changes by a qRT-PCR analysis in the tumors from the different
groups (n = 5 for each group; values represent the mean ± standard
deviation).*Indicates a significant difference compared with the control group
(p < 0.05). # Indicates a significant difference compared with MECUS group (p
< 0.05).
(Xia et al., 2012). Thus, we selected the lowest ultrasound
frequency of 1.7MHz in S5-1 transducer (IE33) in our study in
order to go through the skull to increase the BTB permeability.
Because the temporal bone is the thinnest bone in the skull, we
selected the temporal bone as the ultrasound window. In our
preliminary experiment, we found leakage of red blood cells in
normal brain tissue when the mechnical index of the ultrasound
was 1.4. So the mechnical index of 1.3 was adopted in this study
and we found no leakage of red cells. The duration of ultrasound
sonication was 10min according to our previous study (Zhang
et al., 2016). The concentration of microbubbles in blood will
keep high level within this time.
In this study, we quantitatively and qualitatively investigated
the EB deposition in the glioma tissues. EB binds with albumin,
the smallest macromolecular component, when injected into
blood vessels. It is similar to many small molecular agents
that bind effectively to albumin (Saunders et al., 2015). Under
normal conditions, the BTB can prevent EB from entering
the tumor tissues. However, EB can penetrate into the tumor
interstitium when the BTB permeability increases. In our study,
we found that the EB extravasation in the MEUS groups
exhibited a significant increase compared with the control group
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FIGURE 6 | Hematoxylin-eosin-stained brain samples from the different groups. A histological analysis showing no relevant differences in the brain tissues
from the different groups. (A) Control group. (B) Microbubble-enhanced continued diagnostic ultrasound group. (C) Microbubble-enhanced intermittent diagnostic
ultrasound group.
FIGURE 7 | TUNEL-stained brain samples from the different groups
(scale bar = 40um). TUNEL staining showing no apoptosis in the normal
brain tissues from the different groups. (A) Positive control in tumor. (B)
Control group. (C) Microbubble-enhanced continued diagnostic ultrasound
group. (D) Microbubble-enhanced intermittent diagnostic ultrasound group.
(Figure 1). This finding indicates that diagnostic ultrasound,
in the presence of microbubbles, induces cavitation, which
increases the BTB permeability and causes EB to leak out. The
MEIUS group had more EB extravasation than the MECUS
group. Other investigators had also shown that intermittent
insonification produce more renal hemorrhage than continuous
insonification after the administration of microbubbles (Wible
et al., 2002). Their results support the observation in our study.
With intermittent insonification, microbubbles may circulate
undisturbed during the intervals between ultrasound exposures.
During this period, the microbubbles have time to flow from
larger vessels into the capillary regions. In our study, MEIUS
supplied intermittent time (2 s) for microbubble reperfusion after
acoustic cavitation and offered more cavitation nuclei to activate
than MECUS. In the control group, there was also deposition of
EB in the tumor interstitium. The probable reason is that the
blood vessels in glioma do not have a fully intact BBB and are
somewhat permeable.
In this study, we also adopted the Ktrans of a DCE-MRI to
measure the BTB permeability changes in glioma. DCE-MRI is
used to evaluate microvascular permeability and drug delivery
efficiency after BBB disruption in the brain (Park et al., 2012;
Thompson et al., 2013). In our study, the results obtained using
the Ktrans values to evaluate BTB permeability were similar to the
results of the EB extravasation changes. In addition, the Ktrans
values correlated strongly with the EB extravasation in the tumor.
This result was consistent with a previous study (Yang et al.,
2014), which adopted a Tofts-Kermode model. In our study,
we applied diagnostic ultrasound instead of focused ultrasound.
However, the Ktrans maps showed that there were no obvious
changes as tumor tissue in the surrounding brain tissue after
MEUS. The reasons might be as follows: First, glioma has a highly
angiogenic vascularization, and thus there wasmoremicrobubble
accumulation in the tumor than in the normal brain tissue.
Furthermore, the glioma vasculature is defective and vulnerable,
which becomes a sensitive target for acoustic cavitation. Second,
the Ktrans maps did not have enough sensitivity to distinguish
minimal changes in the BBB permeability of the surrounding
normal brain tissue.
In our study, we investigated the mechanism by which the
BTB permeability is increased by MEUS. Some studies show
that ultrasound irradiation, combined with microbubbles, opens
the BBB by paracellular and transcellular pathways. The integral
tight junction proteins are claudins, occludin and junctional
adhesion molecules (JAMs). Studies demonstrate that ultrasound
combined with microbubbles cause expression changes of tight
junction proteins, such as claudin-5, ZO-1 and occluding, in the
endothelial cell membrane of the BBB (Sheikov et al., 2008).
JAM-A is implicated in a variety of physiologic and pathologic
processes involving cellular adhesion, such as tight junction
assembly (Yeung et al., 2008). In this study, we found that
MEUS decreased JAM-A expression in glioma. Thus, we can
conclude the down-regulation of JAM-A expression in glioma
affects the formation of tight junctions in the BTB, and this
might be one reason for the increasing BTB permeability that is
induced by MEUS. KCa channels are symbolic proteins and play
an important role in the transcellular pathway regulation of the
BTB permeability. These proteins are mainly responsible for the
transcellular vesicular transport of the macromolecular through
the brain endothelial cell protoplasmic membrane (Ningaraj
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et al., 2003). In this study, we found that MEUS increased the
KCa channels expression in glioma. Thus, we can conclude that
the up-regulation of the KCa channels expression in glioma to
affect transcellular pathway of crossing BTB might be one reason
for the increasing BTB permeability induced by MEUS.
In this study, since the diagnostic ultrasound provides 2-D
plane energy scanning, the normal brain tissue could also affected
by the scanned diagnostic ultrasound exposure. However, we
did not find microscopic damage in the normal brain tissue.
The probable reason might be that the diagnostic ultrasound in
this study had less output (MI = 1.3). Meanwhile, the glioma
vasculature is defective and vulnerable, making it more sensitive
than normal brain capillaries to acoustic cavitation. Therefore, we
found that MEUS increased the BTB permeability in glioma, and
we did not find microscopic damage to the normal brain tissue.
Despite these findings, this study has many limitations. For
example, we did not precisely measure the ultrasound power after
it went through the skull. Additionally, we did not evaluate the
long-term histological effect of theMEUS treatment on the brain.
In summary, MEUS increased the BTB permeability in
a rat glioma model without causing damage to the normal
brain tissue, at least, immediately after the procedure. The
mechanism might involve affecting formation of tight junctions
by reducing JAM-A expression and promoting pinocytosis by
increasing KCa channels expression in glioma. Additionally, the
Ktrans value could be a non-invasive method to evaluate the
BTB permeability in rat glioma after a microbubble-enhanced
ultrasound treatment. These findings might provide some new
guidance for glioma drug therapy.
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